Answers are grounded in this paper and cite their sources.
In a pre-exposure prophylaxis program for Kenyan women, we detected tenofovir-diphosphate in 61% (125/201) of randomly selected dried blood spots collected at the first follow-up visit. Tenofovir-diphosphate was detected more frequently among women who had partners living with human immunodeficiency virus, who were not pregnant, and who were ≥24 years.
No takes yet. Share an insight, caveat, or question.
Pintye et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: